16:03 , Apr 18, 2018 |  BC Innovations  |  Distillery Therapeutics

Cancer

INDICATION: Breast cancer Patient sample, cell culture and mouse studies suggest inhibiting CDC25A, CDC25B and CDC25C could help treat breast cancer. In breast cancer patients, high tumor levels of CDC25A, CDC25B and CDC25C correlated with...
08:00 , Nov 13, 2014 |  BC Innovations  |  Distillery Techniques

Technology: Drug platforms

Approach Summary Licensing status Publication and contact information Drug platforms CD8+ T cells that express phosphopeptide-targeted T cell receptor (TCR) to treat cancer Mouse studies suggest CD8+ T cells expressing TCRs that engage with phosphopeptide...
07:00 , Aug 29, 2013 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Melanoma Cyclic adenosine monophosphate (cAMP); cell division cycle 25B (CDC25B); melanocortin 1 receptor (MC1R) Cell culture studies suggest targeting the MC1R-cAMP-CDC25B...